Fortis Capital Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Fortis Capital Advisors’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$441K	Sell	8,934 -200	-2%	-$10.2K	0.05%	260
2026 Q1	$487K	Buy	9,134 +2,381	+35%	+$140K	0.06%	233
2025 Q4	$420K	Buy	+6,753	New	+$417K	0.06%	215
2025 Q2	–	Sell	-3,861	Closed	-$232K	–	257
2025 Q1	$232K	Buy	3,861 +386	+11%	+$24K	0.05%	229
2024 Q4	$204K	Sell	3,475 -64	-2%	-$3.8K	0.07%	171
2024 Q3	$210K	Buy	+3,539	New	+$202K	0.07%	167
2023 Q2	–	Sell	-2,835	Closed	-$153K	–	355
2023 Q1	$153K	Buy	2,835 +35	+1%	+$1.86K	0.08%	132
2022 Q4	$147K	Buy	+2,800	New	+$142K	0.09%	150

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Fortis Capital Advisors's IHI Position: Q2 2026 in Review

Fortis Capital Advisors reduced its iShares US Medical Devices ETF (IHI) stake by 2.2% in Q2 2026, selling an estimated $10.2K and leaving 8,934 shares worth $441K. The position accounts for 0.05% of the portfolio, ranked #260.

Fortis Capital Advisors first reported a position in IHI in Q4 2022 and has held it in 8 quarters since. The position peaked at $487K in Q1 2026. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Fortis Capital Advisors held 8,934 shares of iShares US Medical Devices ETF worth $441K as of Q2 2026.
Fortis Capital Advisors sold 200 iShares US Medical Devices ETF shares in Q2 2026, an estimated $10.2K.
iShares US Medical Devices ETF made up 0.05% of Fortis Capital Advisors's portfolio in Q2 2026, its #260 holding.
Fortis Capital Advisors first reported a position in iShares US Medical Devices ETF in Q4 2022 and has held it in 8 quarters since.
Fortis Capital Advisors's iShares US Medical Devices ETF position peaked at $487K in Q1 2026.
501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Fortis Capital Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.